5247422025-01-012025-03-315247422025-03-315247422024-03-315247422024-04-012025-03-315247422025-01-012025-03-31in-capmkt:OtherExpenses1Member5247422024-04-012025-03-31in-capmkt:OtherExpenses1Member5247422025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15247422024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15247422025-01-012025-03-31RelatedPartyTransactionDomain15247422024-12-31RelatedPartyTransactionDomain15247422025-03-31RelatedPartyTransactionDomain15247422025-01-012025-03-31RelatedPartyTransactionDomain25247422024-12-31RelatedPartyTransactionDomain25247422025-03-31RelatedPartyTransactionDomain25247422025-01-012025-03-31RelatedPartyTransactionDomain35247422024-12-31RelatedPartyTransactionDomain35247422025-03-31RelatedPartyTransactionDomain35247422025-01-012025-03-31RelatedPartyTransactionDomain45247422024-12-31RelatedPartyTransactionDomain45247422025-03-31RelatedPartyTransactionDomain45247422025-01-012025-03-31RelatedPartyTransactionDomain55247422024-12-31RelatedPartyTransactionDomain55247422025-03-31RelatedPartyTransactionDomain55247422025-01-012025-03-31RelatedPartyTransactionDomain65247422024-12-31RelatedPartyTransactionDomain65247422025-03-31RelatedPartyTransactionDomain65247422025-01-012025-03-31RelatedPartyTransactionDomain75247422024-12-31RelatedPartyTransactionDomain75247422025-03-31RelatedPartyTransactionDomain75247422025-01-012025-03-31RelatedPartyTransactionDomain85247422024-12-31RelatedPartyTransactionDomain85247422025-03-31RelatedPartyTransactionDomain85247422025-01-012025-03-31RelatedPartyTransactionDomain95247422024-12-31RelatedPartyTransactionDomain95247422025-03-31RelatedPartyTransactionDomain95247422025-01-012025-03-31RelatedPartyTransactionDomain105247422024-12-31RelatedPartyTransactionDomain105247422025-03-31RelatedPartyTransactionDomain105247422025-01-012025-03-31RelatedPartyTransactionDomain115247422024-12-31RelatedPartyTransactionDomain115247422025-03-31RelatedPartyTransactionDomain115247422025-01-012025-03-31RelatedPartyTransactionDomain125247422024-12-31RelatedPartyTransactionDomain125247422025-03-31RelatedPartyTransactionDomain125247422025-01-012025-03-31RelatedPartyTransactionDomain135247422024-12-31RelatedPartyTransactionDomain135247422025-03-31RelatedPartyTransactionDomain135247422025-01-012025-03-31RelatedPartyTransactionDomain145247422024-12-31RelatedPartyTransactionDomain145247422025-03-31RelatedPartyTransactionDomain145247422025-01-012025-03-31RelatedPartyTransactionDomain155247422024-12-31RelatedPartyTransactionDomain155247422025-03-31RelatedPartyTransactionDomain155247422025-01-012025-03-31RelatedPartyTransactionDomain165247422024-12-31RelatedPartyTransactionDomain165247422025-03-31RelatedPartyTransactionDomain165247422025-01-012025-03-31RelatedPartyTransactionDomain175247422024-12-31RelatedPartyTransactionDomain175247422025-03-31RelatedPartyTransactionDomain175247422025-01-012025-03-31RelatedPartyTransactionDomain185247422024-12-31RelatedPartyTransactionDomain185247422025-03-31RelatedPartyTransactionDomain185247422025-01-012025-03-31RelatedPartyTransactionDomain195247422024-12-31RelatedPartyTransactionDomain195247422025-03-31RelatedPartyTransactionDomain195247422025-01-012025-03-31RelatedPartyTransactionDomain205247422024-12-31RelatedPartyTransactionDomain205247422025-03-31RelatedPartyTransactionDomain205247422025-01-012025-03-31RelatedPartyTransactionDomain215247422024-12-31RelatedPartyTransactionDomain215247422025-03-31RelatedPartyTransactionDomain215247422025-01-012025-03-31RelatedPartyTransactionDomain225247422024-12-31RelatedPartyTransactionDomain225247422025-03-31RelatedPartyTransactionDomain225247422025-01-012025-03-31RelatedPartyTransactionDomain235247422024-12-31RelatedPartyTransactionDomain235247422025-03-31RelatedPartyTransactionDomain235247422025-01-012025-03-31RelatedPartyTransactionDomain245247422024-12-31RelatedPartyTransactionDomain245247422025-03-31RelatedPartyTransactionDomain245247422025-01-012025-03-31RelatedPartyTransactionDomain255247422024-12-31RelatedPartyTransactionDomain255247422025-03-31RelatedPartyTransactionDomain255247422025-01-012025-03-31RelatedPartyTransactionDomain265247422024-12-31RelatedPartyTransactionDomain265247422025-03-31RelatedPartyTransactionDomain265247422025-01-012025-03-31RelatedPartyTransactionDomain275247422024-12-31RelatedPartyTransactionDomain275247422025-03-31RelatedPartyTransactionDomain275247422025-01-012025-03-31RelatedPartyTransactionDomain285247422024-12-31RelatedPartyTransactionDomain285247422025-03-31RelatedPartyTransactionDomain285247422025-01-012025-03-31RelatedPartyTransactionDomain295247422024-12-31RelatedPartyTransactionDomain295247422025-03-31RelatedPartyTransactionDomain295247422025-01-012025-03-31RelatedPartyTransactionDomain305247422024-12-31RelatedPartyTransactionDomain305247422025-03-31RelatedPartyTransactionDomain305247422025-01-012025-03-31RelatedPartyTransactionDomain315247422024-12-31RelatedPartyTransactionDomain315247422025-03-31RelatedPartyTransactionDomain315247422025-01-012025-03-31RelatedPartyTransactionDomain325247422024-12-31RelatedPartyTransactionDomain325247422025-03-31RelatedPartyTransactionDomain325247422025-01-012025-03-31RelatedPartyTransactionDomain335247422024-12-31RelatedPartyTransactionDomain335247422025-03-31RelatedPartyTransactionDomain335247422025-01-012025-03-31RelatedPartyTransactionDomain345247422024-12-31RelatedPartyTransactionDomain345247422025-03-31RelatedPartyTransactionDomain345247422025-01-012025-03-31RelatedPartyTransactionDomain355247422024-12-31RelatedPartyTransactionDomain355247422025-03-31RelatedPartyTransactionDomain355247422025-01-012025-03-31RelatedPartyTransactionDomain365247422024-12-31RelatedPartyTransactionDomain365247422025-03-31RelatedPartyTransactionDomain365247422025-01-012025-03-31RelatedPartyTransactionDomain375247422024-12-31RelatedPartyTransactionDomain375247422025-03-31RelatedPartyTransactionDomain375247422025-01-012025-03-31RelatedPartyTransactionDomain385247422024-12-31RelatedPartyTransactionDomain385247422025-03-31RelatedPartyTransactionDomain385247422025-01-012025-03-31RelatedPartyTransactionDomain395247422024-12-31RelatedPartyTransactionDomain395247422025-03-31RelatedPartyTransactionDomain395247422025-01-012025-03-31RelatedPartyTransactionDomain405247422024-12-31RelatedPartyTransactionDomain405247422025-03-31RelatedPartyTransactionDomain405247422025-01-012025-03-31RelatedPartyTransactionDomain415247422024-12-31RelatedPartyTransactionDomain415247422025-03-31RelatedPartyTransactionDomain415247422025-01-012025-03-31RelatedPartyTransactionDomain425247422024-12-31RelatedPartyTransactionDomain425247422025-03-31RelatedPartyTransactionDomain425247422025-01-012025-03-31RelatedPartyTransactionDomain435247422024-12-31RelatedPartyTransactionDomain435247422025-03-31RelatedPartyTransactionDomain435247422025-01-012025-03-31RelatedPartyTransactionDomain445247422024-12-31RelatedPartyTransactionDomain445247422025-03-31RelatedPartyTransactionDomain445247422025-01-012025-03-31RelatedPartyTransactionDomain455247422024-12-31RelatedPartyTransactionDomain455247422025-03-31RelatedPartyTransactionDomain455247422025-01-012025-03-31RelatedPartyTransactionDomain465247422024-12-31RelatedPartyTransactionDomain465247422025-03-31RelatedPartyTransactionDomain465247422025-01-012025-03-31RelatedPartyTransactionDomain475247422024-12-31RelatedPartyTransactionDomain475247422025-03-31RelatedPartyTransactionDomain475247422025-01-012025-03-31RelatedPartyTransactionDomain485247422024-12-31RelatedPartyTransactionDomain485247422025-03-31RelatedPartyTransactionDomain485247422025-01-012025-03-31RelatedPartyTransactionDomain495247422024-12-31RelatedPartyTransactionDomain495247422025-03-31RelatedPartyTransactionDomain495247422025-01-012025-03-31RelatedPartyTransactionDomain505247422024-12-31RelatedPartyTransactionDomain505247422025-03-31RelatedPartyTransactionDomain505247422025-01-012025-03-31RelatedPartyTransactionDomain515247422024-12-31RelatedPartyTransactionDomain515247422025-03-31RelatedPartyTransactionDomain515247422025-01-012025-03-31RelatedPartyTransactionDomain525247422024-12-31RelatedPartyTransactionDomain525247422025-03-31RelatedPartyTransactionDomain525247422025-01-012025-03-31RelatedPartyTransactionDomain535247422024-12-31RelatedPartyTransactionDomain535247422025-03-31RelatedPartyTransactionDomain535247422025-01-012025-03-31RelatedPartyTransactionDomain545247422024-12-31RelatedPartyTransactionDomain545247422025-03-31RelatedPartyTransactionDomain545247422025-01-012025-03-31RelatedPartyTransactionDomain555247422024-12-31RelatedPartyTransactionDomain555247422025-03-31RelatedPartyTransactionDomain555247422025-01-012025-03-31RelatedPartyTransactionDomain565247422024-12-31RelatedPartyTransactionDomain565247422025-03-31RelatedPartyTransactionDomain565247422025-01-012025-03-31RelatedPartyTransactionDomain575247422024-12-31RelatedPartyTransactionDomain575247422025-03-31RelatedPartyTransactionDomain575247422025-01-012025-03-31RelatedPartyTransactionDomain585247422024-12-31RelatedPartyTransactionDomain585247422025-03-31RelatedPartyTransactionDomain585247422025-01-012025-03-31RelatedPartyTransactionDomain595247422024-12-31RelatedPartyTransactionDomain595247422025-03-31RelatedPartyTransactionDomain595247422025-01-012025-03-31RelatedPartyTransactionDomain605247422024-12-31RelatedPartyTransactionDomain605247422025-03-31RelatedPartyTransactionDomain605247422025-01-012025-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares524742CAPLIPOINTNOTLISTEDINE475E01026CAPLIN POINT LABORATORIES LIMITEDMain BoardEquity2024-04-012025-03-312025-05-152025-05-07INRCroresQuarterlyFourth quarterSingle segmentPharmaceutical Formualtions2025-05-1511:45:002025-05-1513:10:00trueCash Flow IndirectDeclaration of unmodified opiniontruetrueNoNAfalsetrue2025-02-07https://www.caplinpoint.net/wp-content/uploads/2021/07/Related-Party-Transaction-Policy.pdffalsefalseDefault on loans and debt securities is not applicable.2025-01-012025-03-31AuditedStandalone173610000041250000021486000003425000001739000003660000014390000040000060900000288800000104700000011016000000110160000023630000030000023660000008650000000000865000000-2200000862800000152000000211.3711.350011.3711.351 The above Audited Standalone financial Results for the Quarter and Year ended March 31 2025 were recommended by the Audit Committee and approved by the Board of Directors at their respective meetings held on May 15 2025. <BR> <BR> 2 The Audited Standalone financial results of the Company have been prepared in accordance with the Indian Accounting Standards prescribed under Section 133 of the Companies Act 2013 the Act read with relevant rules issued thereunder Ind AS and other accounting principles generally accepted in India and in terms of Regulation 33 of the SEBI Listing Obligations and Disclosure Requirements Regulations 2015. <BR> <BR> 3 The Company is engaged in the sole activity of carrying on the business of Pharmaceutical Formulations and therefore has only one reportable segment in accordance with Ind AS 108 Operating Segments. Hence no separate segment reporting is applicable to the Company. <BR> <BR> 4 Other Income and Profit Before Tax for the Quarter and Year ended March 31 2025 includes Dividend of Rs.15.14 Crores and Rs. 35.53 Crores as against Rs. 18.09 Crores and Rs. 37.54 Crores for the Quarter and Year ended March 31 2024 respectively received from Caplin Point Far East Limited Hong Kong wholly owned subsidiary. <BR> <BR> 5 During the quarter and year ended March 31 2025 the Company has allotted NIL equity shares and 69950 equity shares of Rs. 2 each under the Employees Stock Option Schemes respectively and the total number of equity shares of the Company stands at 76011696 as at March 31 2025 and 75941746 as at March 31 2024. The Company had allotted NIL shares and 39000 shares during the quarter ended and year ended March 31 2024 respectively. <BR> <BR> 6 The Results for the year ended March 31 2025 presented above have been audited by the Statutory Auditors of the Company. <BR> <BR> 7 The Board of Directors at their meeting held on May 15 2025 approved an interim dividend of Rs. 3.00 150% per equity share of Rs. 2 each for the Financial Year 2024 25. <BR> <BR> 8 The figures for the quarter ended March 31 2025 and March 31 2024 are balancing figures between the audited figures in respect of full financial year and the published year to date figures upto the third quarter of the relevant financial year which have been subjected to limited review by the Statutory Auditors. <BR> <BR> 9 Previous periods figures have been regrouped reclassified to be in conformity with current periods classification disclosure wherever necessary.2024-04-012025-03-31AuditedStandalone75241000001345900000887000000013664000007717000002436000005213000001200000247700000130140000044533000004416700000044167000001029000000-720000010218000000339490000000003394900000-1000000339390000015200000021685730000044.6744.470044.6744.47Other Expenses288800000Other Expenses1301400000201590000020640000002100000049111000002458000000188100000755720000087400000988790000066260000031133000001753300000996400000115070000002592000007272900000321400000825690000018144800000152000000168573000001700930000017009300000008500000925000003600000013700000001780000059180000060960000016500000077460000011710000010680000099850000001135500000181448000001200000199900000-4462000000-1211000000000-20750000000024770000000000-346000003553000007544000000-459000000391000000575000000-141960000029971000000001038400000019587000000400000000000000565600000021026000000000000000000003553000006246000000326300000-14020000000000001000000000379900000120000000-38100000017570000001757000000175700000Remeasurements of defined benefit plan-2900000-2900000Remeasurements of defined benefit plan-1300000-1300000-700000-30000000-2200000-1000000Caplin Point Laboratories Limited******Drogueria Saimed de Honduras S.A******Wholly owned step down SubsidiarySale of goods or services1500000000Not Applicable115000000105500000-25100000Caplin Point Laboratories Limited******Nuevos Eticos Neo Ethicals S.A - Guatemala******Wholly owned step down SubsidiarySale of goods or services2500000000Not Applicable80700000035220000031800000Caplin Point Laboratories Limited******Neoethicals CIA.LTDA - Ecuador******Wholly owned step down SubsidiarySale of goods or services1500000000Not Applicable107900000-7030000018100000Caplin Point Laboratories Limited******Neo Ethicals S.A - Nicaragua******Wholly owned step down SubsidiarySale of goods or services1500000000Not Applicable640900000105700000425000000Caplin Point Laboratories Limited******Caplin Point Laboratories Colombia SAS******Wholly owned step down SubsidiarySale of goods or services0Not Applicable031000000Caplin Point Laboratories Limited******Argus Salud Pharma LLP******SubsidiarySale of goods or services150000000Not Applicable299000007740000084000000Caplin Point Laboratories Limited******Caplin Point Far East Limited, (Hong Kong)******Wholly owned SubsidiaryDividend received0Not Applicable15140000000Caplin Point Laboratories Limited******Ashvich Infotek Private Limited******Director and relatives of director are interestedAny other transactionRent & Consultancy155000000Not Applicable1150000010000001200000Caplin Point Laboratories Limited******Ashvich Property Private Limited******Director and relatives of director are interestedAny other transactionRent20000000Not Applicable1700000300000200000Caplin Point Laboratories Limited******Caplin Point Meenakshi CSR Trust******Trust in which Promoter/ Promoter Group are Board of Trustees.Any other transactionCSR Contribution0Not Applicable6980000000Caplin Point Laboratories Limited******Caplin Steriles Limited******SubsidiaryAny other transactionRent50000000Not Applicable30000000Caplin Point Laboratories Limited******Caplin Steriles Limited******SubsidiaryAny other transactionCommon expense recovery50000000Not Applicable250000000Caplin Point Laboratories Limited******Caplin Steriles Limited******SubsidiaryAny other transactionReimbursement Expenses50000000Not Applicable440000000Caplin Point Laboratories Limited******Caplin Steriles Limited******SubsidiarySale of fixed assets50000000Not Applicable40000000Caplin Point Laboratories Limited******Caplin Steriles Limited******SubsidiaryPurchase of goods or services50000000Not Applicable70000000Caplin Point Laboratories Limited******Caplin Steriles Limited******SubsidiaryAny other transactionSale of RODTEP Scrip50000000Not Applicable240000000Caplin Point Laboratories Limited******Dr. Sridhar Ganesan******Managing DirectorRemuneration0Not Applicable250000000Caplin Point Laboratories Limited******Mr. Muralidharan D******Chief Financial OfficerRemuneration0Not Applicable250000000Caplin Point Laboratories Limited******Mr. Partheeban Vivek Siddarth******Chief Operating OfficerRemuneration0Not Applicable80000000Caplin Point Laboratories Limited******Mr. Venkatram G******General Counsel & Company SecretaryRemuneration0Not Applicable180000000Caplin Point Laboratories Limited******Mr. D Sathyanarayanan******Independent DirectorAny other transactionSitting Fees0Not Applicable10000000Caplin Point Laboratories Limited******Dr. C K Gariyali******Independent DirectorAny other transactionSitting Fees0Not Applicable30000000Caplin Point Laboratories Limited******Dr R Nagendran******Independent DirectorAny other transactionSitting Fees0Not Applicable10000000Caplin Point Laboratories Limited******Mr. R Vijayaraghavan******Independent DirectorAny other transactionSitting Fees0Not Applicable20000000Caplin Point Laboratories Limited******Argus Salud Pharma LLP******SubsidiaryAny other transactionShare of profit from the LLP150000000Not Applicable2400000103000008300000Caplin Point Laboratories Limited******Caplin Point laboratories Colombia, SAS, (Colombia)******Fellow subsidaryAny other transactionReimbursement Expenses0Not Applicable200000000Caplin Point Laboratories Limited******Ms Nisha Rajendran******Related Party of the subsidiaryRemuneration0Not Applicable110000000Caplin Point Far East Limited, (Hong Kong)******Nuevos Eticos Neo Ethicals S.A - Guatemala******SubsidiarySale of goods or services750000000Not Applicable400800000759000000614700000Caplin Point Far East Limited, (Hong Kong)******Neoethicals CIA.LTDA - Ecuador******Fellow subsidarySale of goods or services500000000Not Applicable119100000538900000387900000Caplin Point Far East Limited, (Hong Kong)******Neo Ethicals S.A - Nicaragua******Fellow subsidarySale of goods or services600000000Not Applicable800000076900000-144200000Caplin Point Far East Limited, (Hong Kong)******Caplin Point EL salvador S.A De C.V.******Wholly owned Subsidiary CompanySale of goods or services0Not Applicable12100000-82800000-72500000Caplin Point Far East Limited, (Hong Kong)******Caplin One Labs Limited (Formerly Known as Caplin Onco Limited)******Fellow subsidaryLoan0Not Applicable92890000015920000002567400000Caplin Point Far East Limited, (Hong Kong)******Caplin One Labs Limited (Formerly Known as Caplin Onco Limited)******Fellow subsidaryAny other transactionInterest on ECB Loan0Not Applicable7160000076000000147600000Caplin Point Far East Limited, (Hong Kong)******Caplin Point Laboratories Colombia SAS******Wholly owned Subsidiary CompanyInvestment0Not Applicable76000003710000045800000Caplin Point Far East Limited, (Hong Kong)******Caplin Point Laboratories Colombia SAS******Wholly owned Subsidiary CompanyAny other transactionReimbursement Expenses0Not Applicable170000000Caplin Steriles Limited******Caplin Steriles USA Inc.******Wholly owned Subsidiary CompanySale of goods or services0Not Applicable2279000000120900000Caplin Steriles Limited******Ashvich Infotek Private Limited******Directors and their relatives are interestedAny other transactionRent & Consultancy paid20000000Not Applicable65000008000001200000Caplin Steriles Limited******Caplin One Labs Limited (Formerly Known as Caplin Onco Limited)******Fellow subsidarySale of fixed assets0Not Applicable110000000Caplin Steriles Limited******Caplin One Labs Limited (Formerly Known as Caplin Onco Limited)******Fellow subsidarySale of goods or services0Not Applicable20000000Caplin Steriles Limited******Caplin One Labs Limited (Formerly Known as Caplin Onco Limited)******Fellow subsidaryAny other transactionRent0Not Applicable220000000Caplin Steriles Limited******Mr. M Sathya Narayanan******Chief Financial OfficerRemuneration0Not Applicable350000000Caplin Steriles Limited******Dr K C John******Independent DirectorAny other transactionSitting Fees0Not Applicable20000000Caplin Steriles Limited******Ms. S. Rukmani******Key Managerial PersonnelRemuneration0Not Applicable70000000Caplin Steriles Limited******Sunsole Solar Private Limited******Associate CompanyAny other transactionPurchase of Solar Power0Not Applicable1050000000Caplin Steriles Limited******Caplin Steriles USA Inc.******Wholly owned Subsidiary CompanyAny other transactionEquity Investment0Not Applicable216700000159100000375700000Caplin One Labs Limited (Formerly Known as Caplin Onco Limited)******Nuevos Eticos Neo Ethicals S.A - Guatemala******Fellow subsidarySale of goods or services0Not Applicable35100000035100000Caplin One Labs Limited (Formerly Known as Caplin Onco Limited)******Ashvich Infotek Private Limited******Directors and their relatives are interestedAny other transactionRent and Consultancy0Not Applicable10000000Caplin One Labs Limited (Formerly Known as Caplin Onco Limited)******Caplin Point Laboratories Colombia SAS******Fellow subsidaryAny other transactionExpense Reimbursement0Not Applicable370000000Argus Salud Pharma LLP******Drogueria Saimed de Honduras S.A******Fellow subsidarySale of goods or services0Not Applicable20000094000000Argus Salud Pharma LLP******May India Property Private Limited******Patners/directors are interestedAny other transactionShare of profit from the LLP0Not Applicable000Caplin Steriles USA Inc******Dr.Gunasakaran Sambandan******DirectorRemuneration0Not Applicable260000000Nuevos Eticos Neoethicals S.A Guatemala******Neo Ethicals S.A - Nicaragua******Fellow subsidarySale of goods or services0Not Applicable100000078700000104100000Nuevos Eticos Neoethicals S.A Guatemala******Mr. Ashok Gorkey Partheeban******Business Head LatamRemuneration0Not Applicable1260000000Caplin Point Laboratories Limited******Caplin One Labs Limited (Formerly Known as Caplin Onco Limited)******Wholly owned SubsidiarySale of goods or services0Not Applicable2000001000000Caplin Point Laboratories Limited******Caplin One Labs Limited (Formerly Known as Caplin Onco Limited)******Wholly owned SubsidiaryAny other transactionRent Received0Not Applicable320000000Caplin Point Laboratories Limited******Caplin One Labs Limited (Formerly Known as Caplin Onco Limited)******Wholly owned SubsidiaryLoan0Not Applicable600000000Caplin Point Laboratories Limited******Caplin Steriles Limited******SubsidiaryLoan4250000000Not Applicable4300000024150000002458000000Caplin Point Laboratories Limited******Caplin Steriles Limited******SubsidiaryInterest received0Not Applicable13050000000Caplin Point Laboratories Limited******Mr. S Deenadayalan******Independent DirectorAny other transactionSitting Fees0Not Applicable30000000Caplin Point Far East Limited, (Hong Kong)******Drogueria Saimed de Honduras S.A******Wholly owned Subsidiary CompanySale of goods or services750000000Not Applicable-159000006643000006580000004201500000AuditedtrueBrahmayya & Co.true2027-04-30